Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. OPSUMIT
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

OPSUMIT

Medicine - Posted on Apr 04 2016 - Updated on Jun 12 2019
Active substance (DCI)
  • macitentan
history (2)
  • 12/2/15

    OPSUMIT (macitentan), endothelin receptor antagonist

    OPSUMIT (macitentan), endothelin receptor antagonist No clinical benefit demonstrated in patients with class II or III funct...
    CAV :
    54321
    icône flèche
  • Economic analysis
    9/17/14

    OPSUMIT (macitentan), endothelin receptor antagonist

    No clinical added value demonstrated in patients with class II or III functional status of pulmonary arterial hypertension b...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • C02KX04
Manufacturer
ACTELION PHARMACEUTICALS FRANCE
Presentation

OPSUMIT 10 mg, comprimé pelliculé (code CIS : 64744086)
plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium de 30 comprimé(s) - Code CIP : 34009 278 246 1 6

All our publications
    Drug therapy Health economics Hypertension Pulmonary and pleural diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
4aByAvdZM4Un9CMk